Michael J Rider - Net Worth and Insider Trading

Michael J Rider Net Worth

The estimated net worth of Michael J Rider is at least $1 Million dollars as of 2024-04-27. Michael J Rider is the Global General Counsel of ResMed Inc and owns about 6,607 shares of ResMed Inc (RMD) stock worth over $1 Million. Details can be seen in Michael J Rider's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael J Rider has not made any transactions after 2024-03-04 and currently still holds the listed stock(s).

Transaction Summary of Michael J Rider

To

Michael J Rider Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael J Rider owns 1 companies in total, including ResMed Inc (RMD) .

Click here to see the complete history of Michael J Rider’s form 4 insider trades.

Insider Ownership Summary of Michael J Rider

Ticker Comapny Transaction Date Type of Owner
RMD ResMed Inc 2024-03-04 Global General Counsel

Michael J Rider Latest Holdings Summary

Michael J Rider currently owns a total of 1 stock. Michael J Rider owns 6,607 shares of ResMed Inc (RMD) as of March 4, 2024, with a value of $1 Million.

Latest Holdings of Michael J Rider

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RMD ResMed Inc 2024-03-04 6,607 218.06 1,440,722

Holding Weightings of Michael J Rider


Michael J Rider Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael J Rider has made a total of 6 transactions in ResMed Inc (RMD) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in ResMed Inc is the sale of 81 shares on March 4, 2024, which brought Michael J Rider around $14,580.

Insider Trading History of Michael J Rider

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael J Rider Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael J Rider Ownership Network

Ownership Network List of Michael J Rider

No Data

Ownership Network Relation of Michael J Rider


Michael J Rider Owned Company Details

What does ResMed Inc do?

Who are the key executives at ResMed Inc?

Michael J Rider is the Global General Counsel of ResMed Inc. Other key executives at ResMed Inc include Chief Financial Officer Brett Sandercock , Chief Executive Officer Michael J. Farrell , and President and COO Robert Andrew Douglas .

ResMed Inc (RMD) Insider Trades Summary

Over the past 18 months, Michael J Rider made 6 insider transaction in ResMed Inc (RMD) with a net sale of 381. Other recent insider transactions involving ResMed Inc (RMD) include a net sale of 72,983 shares made by Michael J. Farrell , a net sale of 23,280 shares made by Robert Andrew Douglas , and a net sale of 37,000 shares made by Brett Sandercock .

In summary, during the past 3 months, insiders sold 23,816 shares of ResMed Inc (RMD) in total and bought 0 shares, with a net sale of 23,816 shares. During the past 18 months, 183,814 shares of ResMed Inc (RMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 183,814 shares.

ResMed Inc (RMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ResMed Inc Insider Transactions

No Available Data

Michael J Rider Mailing Address

Above is the net worth, insider trading, and ownership report for Michael J Rider. You might contact Michael J Rider via mailing address: 9001 Spectrum Center Blvd, San Diego Ca 92123.

Discussions on Michael J Rider

No discussions yet.